Already confirmed:
Clinic Director
Clinic for Anaesthesiology and Intensive Care Medicine
Essen University Hospital (AöR)
Clinical and scientific career
from 10/2022 Deputy Medical Director, Essen University Hospital
from 02/2020 Clinic Director, Clinic for Anaesthesiology & Intensive Care Medicine, Essen University Hospital
from 02/2020 Full Professor of ‘Anaesthesiology & Anaesthesiological Intensive Care Medicine’ at the University of Duisburg-Essen (UDE)
from 07/2018 ‘Associate Professor’ for Anaesthesiology, Ruprecht-Karls-University, Medical Faculty Heidelberg
from 04/2017 Head Senior Physician, Clinic for Anaesthesiology, Heidelberg University Hospital
09/2015 ‘Venia Legendi’ for the subject Anaesthesiology, Ruprecht-Karls-University, Medical Faculty Heidelberg
04/2014 Additional qualification in ‘Special anaesthesiological intensive care medicine’
from 01/2014 Senior Physician, Clinic for Anaesthesiology, Heidelberg University Hospital
07/2013 - 12/2013 Senior consultant, Department of Anaesthesiology, Heidelberg University Hospital
05/2010 Specialist in anaesthesiology
10/2007 Additional qualification in ‘Emergency Medicine’
Since 01/2005 Research assistant, Department of Anaesthesiology, Heidelberg University Hospital
Selected research funding
05/2021 Project funding from the Dietmar Hopp Foundation
Project title: ‘Next-Generation Sequencing diagnostics of bacteremia in Pediatric Sepsis’ (Next GeneSiPS-Trial) (funding amount: € 431,000)
12/2020 Project funding from the Innovation Fund of the G-BA
Project title: ‘Optimisation of sepsis therapy on the basis of patient-specific digital precision diagnostics’ (DigiSep-Trial) (funding volume: €3,171,100)
02/2019 Project funding from the Dietmar Hopp Foundation
Project title: ‘Next-generation sequencing diagnostics of bacteremia in sepsis’ (Next GeneSiS-Trial) (funding volume: €504,692)
09/2017 Grant from the German Research Foundation (DFG)
Project title: ‘Methylglyoxal (MG)-related carbonyl stress in sepsis’ (GZ: BR4154/2-1; funding volume: €251,725)
Selected scientific prizes
06/2024 Science Award of the Stifterverband 2024 - Forschung im Verbund, Fraunhofer Annual Conference, 12 June 2024 / ‘Next-generation diagnostics for pathogen identification in infectious diseases in intensive care medicine’
02/2019 1st place ‘SIK Innovation Award 2019’, 15th Stuttgart Intensive Care Congress, ‘Next Generation Sequencing (NGS)-based pathogen diagnostics in sepsis’
University education
10/2013 - 09/2015 ‘Master of Health Business Administration (MHBA)’, Friedrich-Alexander-University Erlangen-Nuremberg
2001-2005 Doctorate, Faculty of Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg
11/2004 Medical examination & licence to practise medicine
2000-2003 Study of human medicine, Faculty of Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg
1998-2000 Study of human medicine, Ruprecht-Karls-University Heidelberg
Medical and Molecular Microbiology Unit
Faculty of Science and Medicine
Director, National Reference Center for Emerging Antibiotic Resistance (Switzerland)
University of Fribourg (Switzerland)
Laurent Poirel is Associate Professor at the “Emerging Resistance to Antibiotics” Research Unit and Director of the Swiss National Reference Center for Emerging Antibiotic Resistance at the University of Fribourg. His research interests emerging mechanisms of resistance to ß-lactams, polymyxins, and quinolones in Gram-negative rods, either in human and veterinary medicine. He is specialized on the genetics of acquisition of antibiotic (ß-lactams, quinolones, polymyxins) resistance genes in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii and discovery of novel antibiotic resistance mechanisms in those species. He is the author of more than 640 publications in international journals, his Google Scholar H-index being 146.
He is the Editor-in-Chief of the European Journal of Clinical Microbiology and Infectious Diseases and Associate Editor of two highly-ranked journals, i.e. Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Agents.
He has co-invented a series of rapid diagnostic tests for detection of emerging resistance traits, including the Carba NP test. In addition, he is co-inventor of a series of 15 patents mainly corresponding to rapid diagnostic tests or antibiotic selective media.